Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy

Autor: Hughes, Timothy P., Branford, Susan, White, Deborah L., Reynolds, John, Koelmeyer, Rachel, Seymour, John F., Taylor, Kerry, Arthur, Chris, Schwarer, Anthony, Morton, James, Cooney, Julian, Leahy, Michael F., Rowlings, Philip, Catalano, John, Hertzberg, Mark, Filshie, Robin, Mills, Anthony K., Fay, Keith, Durrant, Simon, Januszewicz, Henry, Joske, David, Underhill, Craig, Dunkley, Scott, Lynch, Kevin, Grigg, Andrew
Zdroj: In Blood 15 November 2008 112(10):3965-3973
Databáze: ScienceDirect